Ali H. Moussa

Ali H. Moussa

Hematology | Oncology

12697 E 51st St
Tulsa, OK 74146

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.

Journal: British journal of cancer

Published: April 20, 2016

Showing 1-1 of 1

Last Updated: 09/26/2026